SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-05-000539
Filing Date
2005-04-06
Accepted
2005-04-06 16:18:17
Documents
3
Period of Report
2005-05-11
Effectiveness Date
2005-04-06

Document Format Files

Seq Description Document Type Size
1 bp910751.htm DEF 14A 202687
2 GRAPHIC image001.jpg GRAPHIC 9917
3 GRAPHIC image002.jpg GRAPHIC 32137
  Complete submission text file 0001206774-05-000539.txt   246492
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 05737158
SIC: 2836 Biological Products, (No Diagnostic Substances)